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1. MRI, Magnetic Resonance Influenced freezing 
2. +dP/dt , the peak positive dP/dt  
3. –dP/dt , the peak negative dP/dt 
4. ATP, adenosine triphosphate 
5. UW, University of Wisconsin cardioplegic solution 





A new supercooling system using a variable magnetic field has been recently developed. 
Subzero non-freezing preservation has been thought to be a beneficial method because 
of the lower metabolic rate. The purpose of this study was to evaluate the hemodynamic 




Rats hearts were perfused ex vivo for 120 minutes after 24 hours’ preservation in two 
groups (n=6 each): (1) conventional storage group, in which the hearts were stored at 
4°C, and (2) the subzero group, in which the hearts were preserved at -3°C in a variable 
magnetic field.  
 
Results: 
Reperfusion cardiac performance after preservation was significantly preserved in the 
subzero group compared with the conventional group with respect to heart rate, 
coronary flow, the peak positive dP/dt, and the peak negative dP/dt (p<0.05). Edema 
after reperfusion was significantly decreased (p<0.05), and the adenosine triphosphate 
level was higher in the subzero group (p<0.05). 
 
Conclusions: 
The rat hearts preserved in a variable magnetic field at -3°C showed better 
hemodynamic and metabolic performance than those preserved using conventional 




The limited availability of donor hearts is still a major problem in clinical heart 
transplantation. Currently, the safe ischemia time for a heart is limited to 5 or 6 hours 
of cold (2°C-4°C) ischemic storage.1, 2 Extending the preservation time could increase 
the stock of donors and allow optimal immunologic matching of donors with potential 
recipients. 
Preservation at a lower temperature may be advantageous, because the activity of 
enzymes shows a 1.5 - 2.0-fold decrease for every 10°C decrease according to van’t Hoff ’s 
rule.3, 4 Several organ preservation experiments at subzero temperatures have been 
reported using cryoprotectants such as polyethylene glycol, 2,3-butanediol, or 
anti-freeze protein. 5, 6, 7 On the other hand, other groups have reported subzero organ 
preservation using a special supercooling refrigerator. 8, 9 However, the functional 
advantage of heart preservation in these refrigerators has not been reported. 
 A Japanese company engaged in the development of food-freezing technology has 
devised a food-freezing technique, named “MRI, Magnetic Resonance Influenced 
freezing”, that does not compromise the quality of the thawed food. In this method, the 
refrigeration chamber can generate a non-frozen condition below the freezing point, 
which is a so-called supercooled state, easily and stably, by applying a variable magnetic 
field within the chamber. For organ preservation in medical transplantation, it is 
assumed that cooling to ice temperature results in reduction of organ metabolism, 
implying greater hypothermic preservation. Hearts preserved by supercooling would 
thus have better physiologic functions than those stored at 4°C. The aim of this present 
study was to evaluate cardiac physiologic functions after preservation by supercooling 




 The heart rates at 30, 60, 90, and 120 minutes after reperfusion in each group are 
shown in Figure 3A. The heart rates in the subzero group (CAS) at 90 and 120 minutes 
were significantly higher than in the conventional storage group (4℃) (148.1±34.0 beats 
per minutes vs. 82.8±22.4 beats per minute at 90 minutes and 137.0±27.4 beats per 
minutes vs. 94.0±17.6 beats per minute at 120 minutes, p<0.05).  
 
Coronary flow 
The coronary flows at 30, 60, 90, and 120 minutes after reperfusion in each group are 
shown in Figure 3B. The coronary flows at 90 and 120 minutes were significantly 
greater in the subzero group (CAS) than in the conventional storage group (4℃) 
(2.76±0.46 ml/min vs. 1.53±0.36 ml/min at 90 minutes and 3.26±0.66 ml/min vs. 
1.48±0.37 ml/min at 120 minutes, p<0.05).  
 
Cardiac functions 
 The peak positive dP/dt (+dP/dt) and the peak negative dP/dt (-dP/dt) are shown in 
Figure 4. +dP/dt and –dP/dt were significantly higher in the subzero group (CAS) than 
in the conventional storage group (4℃) at 30, 60, 90, and 120 min after reperfusion 
(+dP/dt: 289.1±154.6 vs. 32.4±25.3 mmHg/sec at 30 minutes, 361.5±222.0 vs. 53.9±24.6 
mmHg/sec at 60 minutes, 333.5±220.5 vs. 70.5±23.6 mmHg/sec at 90 minutes, and 
458.2±262.4 vs. 63.9±21.7 mmHg/sec at 120 minutes, p<0.05) (-dP/dt: -179.9±76.4 vs. 
-23.9±19.0 mmHg/sec at 30 minutes, -241.3±92.9 vs. -48.0±19.6 mmHg/sec at 60 
minutes, -276.7±228.6 vs. 60.0±23.4 mmHg/sec at 90 minutes, and -351.1±247.6 vs. 
-52.2±15.9 mmHg/sec at 120 minutes, p<0.05). 
 
Tissue water content 
 The tissue water content after reperfusion was higher in the conventional storage 
group (4℃) (82.6±1.2) than in the subzero group (CAS) (78.4±1.8; p<0.05; Figure 5A). 
 Adenosine triphosphate (ATP) levels 
 The ATP concentration after reperfusion was significantly higher in the subzero group 
(CAS) (245.8±40.0 mol/g) than in the conventional storage group (4℃) (134.5±22.4 
mol/g) (p<0.05; Figure 5B). 
 
Discussion  
In this study, conventional heart preservation at 4°C and heart preservation in a 
subzero environment in a variable magnetic field were compared. From the present 
results for heart rate, dP/dt, and coronary flow, the subzero preservation group showed 
better preservation of cardiac function after reperfusion. The results for tissue ATP and 
tissue water content showed that the subzero preservation group also had better a 
preservation state with little edema. From this it is understood that subzero heart 
preservation in a variable magnetic field environment is promising for better recovery 
of metabolism and function than with conventional heart preservation at 4°C. This 
method enables subzero preservation without the use of cryoprotectants, eliminating 
the need for concern about their adverse effects. It is thought that future application of 
this method will make it possible to improve the state of heart preservation and extend 
preservation time in heart transplantation.  
In current clinical practice for heart transplantation, the heart is generally preserved 
for 4-6 h at 4°C. 1, 2 The advantages of the low temperature preservation generally used 
in experiments are the drop in metabolism and suppression of high energy store 
consumption. 3, 4 Metabolism is thought to continue until -60°C, but as seen when 
expressed as an Arrhenius plot, the cell metabolic rate is correlated with temperature. 
When temperature decreases 10°C, the metabolic rate roughly halves. Therefore, it may 
be considered that the drop in metabolism and suppression of high energy store 
consumption are greater with preservation at -3° than with preservation at 4°C.  
There are several reports of subzero preservation using cryoprotectants such as 
polyethylene glycol, 2-3 butanediol or anti-freeze protein with the aim of preservation at 
a lower temperature than conventional preservation at 4°C. 5, 6, 7 These reports also 
state that organ preservation at lower temperatures has the advantages of attenuating 
enzyme activation and suppressing metabolism. To evaluate metabolism in the present 
experiment, it was decided to compare tissue ATP values, which are a well known 
indicator correlated to heart preservation status. 10, 11, 12 Similar to previous studies, in 
the present experiment, tissue ATP was significantly preserved in the subzero 
preservation group, and it was demonstrated that tissue could be stored in a better 
state than with conventional methods. In the clinical application of heart preservation 
using cryoprotectants, which have been used in experiments to take advantage of the 
metabolic inhibition effect of low temperature, there is the problem of adverse effects 
from the cryoprotectants themselves. On this point, since the heart preservation 
method of supercooling within a variable magnetic field enables subzero preservation 
without using cryoprotectants, it has the major advantage of eliminating the concern 
about adverse effects from cryoprotectants, making this method easier to apply 
clinically.  
The freezing technology under a magnetic field environment such as was used in the 
present experiment was developed by a Japanese company engaged in the development 
of food-freezing technology, with the aim of cryopreservation that causes little cellular 
damage in food. There have been several reported studies to date similar to the present 
one on organ preservation in a subzero environment with the application of magnetic 
fields or voltage. 8,9 In the report of Okamoto et al., 3,000 V were applied in preservation 
of a rat lung in a -2°C environment, and the preservation state 60 min after perfusion 
was reported to be better than with conventional lung preservation at 4°C. In a report 
by Monzen et al., a heart and liver were preserved for 24 hours and a kidney for 72 
hours at -4°C with application of 100 V and 500 V, respectively. Enzymes that leaked 
into the preservation fluid were measured, and the preservation state was reported to 
be better than with conventional preservation of 4°C.8 However, there are no reported 
evaluations of cardiac function after reperfusion for heart preservation using this 
technology. In the present experiment, since the peak positive dP/dt and the peak 
negative dP/dt measurement results were better with the supercooling heart 
preservation method in a variable magnetic field than with conventional preservation, 
it was demonstrated for the first time that systolic performance and diastolic 
performance are better maintained with supercooling than with conventional 
preservation. Combining the results for heart rate and coronary flow, it was also found 
that a better state of preservation was maintained than with conventional preservation 
for cardiac function. 
However, preservation at subzero temperatures, while enabling metabolic inhibition 
and good preservation, is also reported to have the associated risks of freezing or 
breakdown of cellular homeostasis, which is maintained by Na-K ATPase activity. 13 
With respect to these risks, the present results showed high ATP levels and only mild 
tissue edema after reperfusion. These findings indicate that subzero heart preservation 
in a variable magnetic field environment can preserve hearts without causing the low 
temperature damage that is a potential concern.  
Recently, preservation methods involving continuous perfusion 14, 15, 16 have been 
clinically applied 17 as a means of extending preservation time other than 
low-temperature preservation. However, these methods are somewhat complicated; for 
example, they use complex circuits and require a perfusion solution. In comparison, the 
present method of supercooling preservation in a variable magnetic field has the 
advantage of not requiring complex procedures such as a setup for continuous perfusion. 
Conversely, continuous perfusion preservation methods can wash out metabolic 
products and provide a constant energy source, thus providing an improved 
preservation state. Therefore, since the techniques and concept differ from the present 
method, it may be that by combining the two approaches an even greater improvement 
in the state of preservation can be expected. The ability to transport organs between 
countries for transplantation, which may become possible through further 
improvements to make this refrigerator portable, could also help transplantation 
medicine to spread more widely.  
In conclusion, the results of the present study demonstrate that better preservation in 
terms of both cardiac function and metabolism, without causing low temperature 
damage, was possible with supercooled heart preservation in a variable magnetic field 
when compared with conventional preservation at 4°C in 24-hour preservation of rat 





This experimental model was Isolated heart perfusion model according to 
Langendorff apparatus with a Krebs-Henseleit solution. In the future, comparative 
investigations with blood such as heterotopic transplantation will be needed. 
Technology for freezing in a variable magnetic field has the advantages of no 
concentration gradients and uniform freezing in both the outer and inner parts of food. 
Considering this, these techniques will probably be even more useful in the 
preservation of large solid organs, such as the heart and liver of large animals, than in 
small animals such as rats. In the future, comparative investigations with large 
animals will be needed. Furthermore, since allogeneic transplantation is conducted 
clinically, chronic experiments to compare the state following transplantation and other 
outcomes will be needed in the future. 
 
Materials and methods 
Healthy adult (10-12 weeks old, 250-300 g) Wistar rats were prepared. All animals 
received humane care in accordance with the United States National Institutes of 
Health Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23, 
revised 1996; Bethesda, MD). Each rat was anesthetized by inhalation of diethyl ether 
and intraperitoneal injection of pentobarbital (30 mg/animal). Each rat underwent 
mid-line abdominal and bilateral chest incisions, separating the anterior chest and the 
diaphragm, and was heparinized with 500 IU. The superior vena cava, inferior vena 
cava, and pulmonary artery were dissected, and 4 ℃  University of Wisconsin 
cardioplegic solution (UW; Via Span, Astellas Pharma Inc, Tokyo, Japan) was 
administered thorough the ascending aorta (total 50 ml, 5 ml/min). After that, the heart 
was preserved in a bath filled with UW. 
  
Supercooling system 
 For the preservation of rat hearts by supercooling, a refrigerator named the Cells Alive 
system (CAS) (ABI Co., Ltd., Chiba, Japan) was used. This refrigerator was developed 
to maintain a supercooled state by applying a combination of multiple weak energy 
sources that cause water molecules in the material to vibrate, inhibiting crystallization 
to form ice. Since the entire material is frozen uniformly from outside to inside, the 
water molecules are thawed in the same state as before freezing. As a result, cells can 
be maintained without broken when the food is thawed (Figure 1). This study focused 
on the ability of this technology to maintain a supercooled state, and a preservation 
experiment at -3°C without macroscopic freezing was performed (Figure 2). 
 
Experimental Groups 
 There were two experimental groups: the conventional storage group (n=6), in which 
the hearts were preserved in a 4°C refrigerator, and the subzero group (n=6), in which 
the hearts were preserved in the -3°C Cells Alive System. The hearts in each group were 
preserved for 24 hours. The aorta of the preserved heart was connected to a standard 
Langendorff apparatus and perfused in a retrograde fashion at a constant pressure of 
80 mmHg for 2 hours with a 37℃ Krebs-Henseleit solution prepared in our laboratory 
(in mM: NaCl, 118; KCl, 4.7; MgSO4・7H2O, 1.2; CaCl2・2H2O, 2.5; NaHCO3, 25; glucose, 
11.0; KH2PO4 1.2; pH=7.6) gasified with 95% O2 and 5% CO2. 
 
Functional measurement in the Graft 
 Hemodynamic parameters were monitored using a 3-Fr. latex balloon catheter inserted 
into the left ventricle (LV) via the left atrium and connected to a pressure transducer 
(VO1706TSPL03, Edwards Lifescience) placed at the equivalent height to the heart, in 
combination with a recording system (RM-6000, POLYGRAPH SYSTEM, NIHON 
KOHDEN CORPORATION) . The balloon was inflated and equilibrated to give an 
end-diastolic pressure of 8 mmHg. LV pressure and time derivatives of pressure were 
measured during contraction (+dP/dt) and relaxation (-dP/dt) with the integrated data 
system UCO (UNIQUE MEDICAL Co.,LTD, Tokyo, Japan), and heart rate was 
monitored. Coronary flow was measured in the volumetric cylinder at 30, 60, 90 and 120 
minutes after reperfusion. 
 
Tissue water content 
 Tissue water content (as a percentage) was determined by the difference in wet weight 
and dry weight divided by wet weight and multiplied by 100%. After 120 minutes of 
reperfusion, the hearts were dried to a constant weight at 85°C for up to 48 hours. 
 
Determination of adenosine triphosphate (ATP) levels 
 After 120 minutes of reperfusion, the hearts were immediately immersed in liquid 
nitrogen (-196°C) and stored frozen at -80°C until biochemical analysis. ATP content 
was expressed as micromoles per gram of dry weight. 
 Statistical analysis 
All data are expressed as mean value ± standard deviation. The data were evaluated 
by the Mann-Whitney U-test for 2-group analysis. A value of p < 0.05 was considered 
significant. All statistical analyses were performed using SPSS for Windows version 
16.0 software (SPSS, Chicago, IL). 
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Concept of freezing in a variable magnetic field 
 (A) When the organ is expose to a combination of multiple ultraweak energies, water 
molecules in the organ are vibrated, ice crystallization of water content is inhibited, and 
the supercooled state is maintained. 
(B) When the organ is directly expose to cold air (in a conventional cooling system), ice 
crystallization is initiated, and the ice on the surface obstructs the freezing of the 
internal layers, thereby causing multilayered freezing. The water molecules in the 
internal unfrozen segment are mobilized and sucked up toward the core of ice on the 
surface by capillary phenomenon.  
 
Figure 2 
Myocardial temperature in the conventional storage (4℃) and  a variable magnetic 
field (-3℃, CAS) 
 
Figure 3A 
Heart rate during reperfusion 
The heart rates are significantly higher in the subzero group (CAS) than in the 




Coronary flows during reperfusion 
 The coronary flows are significantly higher in the subzero group (CAS) than in the 




 Changes in The peak positive dP/dt (+dP/dt) (A) and the peak negative dP/dt (-dP/dt)  
(B) 
 +dP/dt and -dP/dt are significantly higher in the subzero group (CAS) than in the 
conventional storage group (4℃) (＊p<0.05). 
 
Figure 5A 
Adenosine triphosphate (ATP) levels in the myocardial tissue at the end of 120 minutes’ 
reperfusion 
The ATP level is significantly higher in the subzero group (CAS) than in the 
conventional storage group (4℃) (p<0.05).  
 
Figure 5B 
Tissue water contents at the end of 120 minutes’ reperfusion 
 The tissue water content is significantly lower in the subzero group (CAS) than in the 
conventional storage group (4℃) (p<0.05).  
 







